Oral Janus kinase inhibitor tablets for rheumatoid arthritis and psoriatic arthritis management. Synthesized by biotechnology firms, supplied via specialized distributors to rheumatology clinics and hospitals; purchased by healthcare networks for long-term therapy in autoimmune disease treatment protocols.